Sage Therapeutics, Inc. SAGE reported a loss of $1.53 per share for the third quarter of 2024, wider than the Zacks Consensus ...

Vaxxas, has announced the company has been granted a licence to develop a next-generation vaccine antigen (DS2).

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

Supported by funds from the National Research University Fund (NRUF), the new center is in UTA’s Science and Engineering Innovation and Research (SEIR) building on W. Mitchell Street. SEIR opened in ...

A picture may be worth a thousand words, but they both have a lot of work to do to catch up to BiomedGPT. A Lehigh University ...

Relating brain activity to behavior is an ongoing aim of neuroimaging research as it would help scientists understand how the brain begets behavior—and perhaps open new opportunities for personalized ...

A picture may be worth a thousand words, but still…they both have a lot of work to do to catch up to BiomedGPT.

Dr Christina Brennan, senior vice president of clinical research for Northwell Health, said local IRBs will also continue to have a role when it comes to patient safety, verification of staff ...

A clinical trial involves the study of the safety, efficacy and/or dosage regimen of a therapeutic intervention (such as a drug) in humans selected according to predetermined criteria of ...

Researchers have identified a groundbreaking link between the CHCHD2 gene and Huntington’s disease (HD), a genetic ...

It's been a while since a new text-to-image generator shook up the generative AI space. However, the mysterious Red Panda generator has done just that, climbing up Artificial Analysis's Text-to ...